146 related articles for article (PubMed ID: 26309689)
1. Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.
Jiang SM; Jia L; Zhang MH
Int J Clin Exp Med; 2015; 8(6):9996-10000. PubMed ID: 26309689
[TBL] [Abstract][Full Text] [Related]
2. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.
Jia L; Zhang MH
World J Gastroenterol; 2005 Feb; 11(6):908-11. PubMed ID: 15682492
[TBL] [Abstract][Full Text] [Related]
3. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
4. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial.
Pratap Mouli V; Benjamin J; Bhushan Singh M; Mani K; Garg SK; Saraya A; Joshi YK
Hepatol Res; 2015 Aug; 45(8):880-9. PubMed ID: 25266207
[TBL] [Abstract][Full Text] [Related]
5. Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy.
Shavakhi A; Hashemi H; Tabesh E; Derakhshan Z; Farzamnia S; Meshkinfar S; Shavakhi S; Minakari M; Gholamrezaei A
J Res Med Sci; 2014 Aug; 19(8):703-8. PubMed ID: 25422653
[TBL] [Abstract][Full Text] [Related]
6. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Sharma P; Sharma BC; Puri V; Sarin SK
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
9. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
10. Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.
Pawar VB; Surude RG; Sonthalia N; Zanwar V; Jain S; Contractor Q; Rathi PM
J Clin Transl Hepatol; 2019 Dec; 7(4):304-312. PubMed ID: 31915599
[No Abstract] [Full Text] [Related]
11. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
[TBL] [Abstract][Full Text] [Related]
12. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
13. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
[TBL] [Abstract][Full Text] [Related]
14. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
15. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
16. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for patients with hepatic encephalopathy.
McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
[TBL] [Abstract][Full Text] [Related]
18. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
19. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
20. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
